Initiation of ARNi and SGLT2i in Patients With HFrEF

Condition:   Heart Failure With Reduced Ejection Fraction Interventions:   Drug: Sacubitril-valsartan;   Drug: SGLT2 inhibitor Sponsor:   Universidade do Porto Recruiting

Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials